Ultragenyx Pharmaceutical Inc. Uncategorized Contracts & Agreements

28 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment dated September 6, 2023 to the Offer Letter between Howard Horn and Ultragenyx Pharmaceutical Inc. dated June 22, 2023
Ultragenyx Pharmaceutical Inc.
Biotechnology
2023
Offer Letter between Howard Horn and Ultragenyx Pharmaceutical Inc. dated June 22, 2023
Ultragenyx Pharmaceutical Inc.
Biotechnology
2023
Amendment, dated September 13, 2022, to Offer Letter by and between Ultragenyx Pharmaceutical Inc. and John R. Pinion II
Ultragenyx Pharmaceutical Inc.
Biotechnology
CA
2022
Amendment No. 3, dated September 13, 2022, to Offer Letter by and between Ultragenyx Pharmaceutical Inc. and Erik Harris
Ultragenyx Pharmaceutical Inc.
Biotechnology
CA
2022
Amendment, dated September 13, 2022, to Offer Letter by and between Ultragenyx Pharmaceutical Inc. and Dennis Huang
Ultragenyx Pharmaceutical Inc.
Biotechnology
CA
2022
Amendment, dated September 13, 2022, to Offer Letter by and between Ultragenyx Pharmaceutical Inc. and Karah Parschauer
Ultragenyx Pharmaceutical Inc.
Biotechnology
CA
2022
Amendment No. 2, dated September 13, 2022, to Offer Letter by and between Ultragenyx Pharmaceutical Inc. and Thomas Kassberg
Ultragenyx Pharmaceutical Inc.
Biotechnology
CA
2022
Amendment No. 2, dated September 13, 2022, to Offer Letter by and between Ultragenyx Pharmaceutical Inc. and Mardi C. Dier
Ultragenyx Pharmaceutical Inc.
Biotechnology
CA
2022
Amendment, dated September 13, 2022, to Offer Letter by and between Ultragenyx Pharmaceutical Inc. and Camille Bedrosian, M.D
Ultragenyx Pharmaceutical Inc.
Biotechnology
CA
2022
Open Market Sale Agreement, dated May 7, 2021, by and between Ultragenyx Pharmaceutical Inc. and Jefferies LLC
Ultragenyx Pharmaceutical Inc.
Biotechnology
NY
2021
Amendment dated October 9, 2020 to the Offer Letter between Mardi C. Dier and Ultragenyx Pharmaceutical Inc. dated August 28, 2020
Ultragenyx Pharmaceutical Inc.
Biotechnology
2020
Offer Letter between Mardi C. Dier and Ultragenyx Pharmaceutical Inc. dated August 28, 2020
Ultragenyx Pharmaceutical Inc.
Biotechnology
2020
Addendum #2, dated June 19, 2019, to Offer Letter dated May 16, 2017 between Ultragenyx Pharmaceutical Inc. and Erik Harris
Ultragenyx Pharmaceutical Inc.
Biotechnology
2019
Addendum #1, dated August 8, 2017, to Offer Letter dated May 16, 2017 between Ultragenyx Pharmaceutical Inc. and Erik Harris
Ultragenyx Pharmaceutical Inc.
Biotechnology
2019
Offer Letter, dated May 16, 2017, by and between Ultragenyx Pharmaceutical Inc. and Erik Harris
Ultragenyx Pharmaceutical Inc.
Biotechnology
2019
Offer Letter, dated August 2, 2018
Ultragenyx Pharmaceutical Inc.
Biotechnology
2018
Turning good science into great medicine
Ultragenyx Pharmaceutical Inc.
Biotechnology
2017
Turning good science into great medicine
Ultragenyx Pharmaceutical Inc.
Biotechnology
CA
2017
Turning good science into great medicine
Ultragenyx Pharmaceutical Inc.
Biotechnology
CA
2017
ULTRAGENYX PHARMACEUTICAL INC. $150,000,000 SALESAGREEMENT
Ultragenyx Pharmaceutical Inc.
Biotechnology
NY
2016
ADDENDUM TWO
Ultragenyx Pharmaceutical Inc.
Biotechnology
2016
Addendum One
Ultragenyx Pharmaceutical Inc.
Biotechnology
2016
CONFIDENTIAL TREATMENT REQUESTED [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential...
Ultragenyx Pharmaceutical Inc.
Biotechnology
2015
Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Biotechnology
CA
2015
LicenseAgreement
Ultragenyx Pharmaceutical Inc.
Biotechnology
NY
2013
ULTRAGENYX PHARMACEUTICAL INC. AMENDMENT TO THE 2011 EQUITYINCENTIVE PLAN
Ultragenyx Pharmaceutical Inc.
Biotechnology
2013
LicenseAgreement
Ultragenyx Pharmaceutical Inc.
Biotechnology
NY
2013
State of Delaware
Ultragenyx Pharmaceutical Inc.
Biotechnology
2013